138 related articles for article (PubMed ID: 12679828)
1. The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results.
Gillette-Guyonnet S; Nourhashemi F; Andrieu S; Cantet C; Micas M; Ousset PJ; Vellas B;
J Nutr Health Aging; 2003; 7(2):91-6. PubMed ID: 12679828
[TBL] [Abstract][Full Text] [Related]
2. Living alone with Alzheimer's disease: cross-sectional and longitudinal analysis in the REAL.FR Study.
Nourhashemi F; Amouyal-Barkate K; Gillette-Guyonnet S; Cantet C; Vellas B;
J Nutr Health Aging; 2005; 9(2):117-20. PubMed ID: 15791356
[TBL] [Abstract][Full Text] [Related]
3. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
[TBL] [Abstract][Full Text] [Related]
4. Recent data on the natural history of Alzheimer's disease: results from the REAL.FR Study.
Cortes F; Gillette-Guyonnet S; Nourhashemi F; Andrieu S; Cantet C; Vellas B;
J Nutr Health Aging; 2005; 9(2):86-93. PubMed ID: 15791351
[TBL] [Abstract][Full Text] [Related]
5. Cognitive function and caregiver burden: predictive factors for eating behaviour disorders in Alzheimer's disease.
Rivière S; Gillette-Guyonnet S; Andrieu S; Nourhashemi F; Lauque S; Cantet C; Salva A; Frisoni G; Vellas B
Int J Geriatr Psychiatry; 2002 Oct; 17(10):950-5. PubMed ID: 12325056
[TBL] [Abstract][Full Text] [Related]
6. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment.
Vellas B; Lauque S; Gillette-Guyonnet S; Andrieu S; Cortes F; Nourhashémi F; Cantet C; Ousset PJ; Grandjean H;
J Nutr Health Aging; 2005; 9(2):75-80. PubMed ID: 15791349
[TBL] [Abstract][Full Text] [Related]
7. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
[TBL] [Abstract][Full Text] [Related]
8. Spared and impaired abilities in community-dwelling patients entering the severe stage of Alzheimer's disease.
Gillioz AS; Villars H; Voisin T; Cortes F; Gillette-Guyonnet S; Andrieu S; Gardette V; Nourhashémi F; Ousset PJ; Jouanny P; Vellas B;
Dement Geriatr Cogn Disord; 2009; 28(5):427-32. PubMed ID: 19907179
[TBL] [Abstract][Full Text] [Related]
9. Determinants of costs of care for patients with Alzheimer's disease.
Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors of emergency hospitalisation in Alzheimer's patients: results of one-year follow-up in the REAL.FR Cohort.
Balardy L; Voisin T; Cantet C; Vellas B;
J Nutr Health Aging; 2005; 9(2):112-6. PubMed ID: 15791355
[TBL] [Abstract][Full Text] [Related]
11. Changes in informal care over one year for elderly persons with Alzheimer's disease.
Andrieu S; Bocquet H; Joel A; Gillette-Guyonnet S; Nourhashemi F; Salva A; Grand A;
J Nutr Health Aging; 2005; 9(2):121-6. PubMed ID: 15791357
[TBL] [Abstract][Full Text] [Related]
12. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease progression in the oldest old compared to younger elderly patient: data from the REAL.FR study.
Nourhashémi F; Gillette-Guyonnet S; Rolland Y; Cantet C; Hein C; Vellas B
Int J Geriatr Psychiatry; 2009 Feb; 24(2):149-55. PubMed ID: 18613005
[TBL] [Abstract][Full Text] [Related]
14. [The French network multicenter study. Predictive factors of hospitalization and management of Alzheimer's disease patients (REAL.FR)].
Gillette-Guyonnet S; Andrieu S; Nourhashémi F; Balardy L; Micas M; Ousset PJ; Vellas B
Rev Med Interne; 2003 Oct; 24 Suppl 3():278s-282s. PubMed ID: 14710444
[TBL] [Abstract][Full Text] [Related]
15. Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR cohort.
Gillette-Guyonnet S; Cortes F; Cantet C; Vellas B;
J Nutr Health Aging; 2005; 9(2):69-73. PubMed ID: 15791348
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.
Cortes F; Nourhashémi F; Guérin O; Cantet C; Gillette-Guyonnet S; Andrieu S; Ousset PJ; Vellas B;
Alzheimers Dement; 2008 Jan; 4(1):22-9. PubMed ID: 18631947
[TBL] [Abstract][Full Text] [Related]
17. [Depression and frontal dysfunction: risks for the elderly?].
Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
[TBL] [Abstract][Full Text] [Related]
18. Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group).
Guerin O; Soto ME; Brocker P; Robert PH; Benoit M; Vellas B;
J Nutr Health Aging; 2005; 9(2):81-4. PubMed ID: 15791350
[TBL] [Abstract][Full Text] [Related]
19. One-year longitudinal evaluation of neuropsychiatric symptoms in Alzheimer's disease. The REAL.FR Study.
Benoit M; Robert PH; Staccini P; Brocker P; Guerin O; Lechowski L; Vellas B;
J Nutr Health Aging; 2005; 9(2):95-9. PubMed ID: 15791352
[TBL] [Abstract][Full Text] [Related]
20. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
Cortes F; Portet F; Touchon J; Vellas B
J Nutr Health Aging; 2007; 11(4):330-7. PubMed ID: 17653493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
